With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Targeting Tumor Suppressor MicroRNAs in Pediatric Acute Lymphoblastic Leukemia||The Johns Hopkins University School of Medicine / Linda Resar, M.D.||Innovation Grants||2014||Maryland|
|Converting the Glioblastoma Multiforme Tumor-Associated Macrophage Phenotype||The Johns Hopkins University School of Medicine / Alan D. Friedman, M.D.||Innovation Grants||2014||Maryland|
|Targeting the Epigenome of Diffuse Intrinsic Pontine Glioma||The Johns Hopkins University School of Medicine / Sama Ahsan, MD||Young Investigator Grants||2014||Maryland|
|Identifying Novel Therapeutic Combinations with 131I-MIBG to Treat Relapsed and Refractory Neuroblastoma||The Regents of the University of California San Francisco / William Clay Gustafson, M.D., Ph.D.||Reach Grants||2014||California|
|Autophagy and mTOR Inhibition in Pediatric Gliomas with BRAF Mutations||University of Colorado Denver / Jean Mulcahy Levy, MD||Young Investigator Grants||2014||Colorado|
|Exploiting Epigenetic Dependencies of Notch1 for Clinical Benefit||University of Colorado Denver / Patricia Ernst, Ph.D.||Innovation Grants||2014||Colorado|
|Targeting the Six1/Eya Transcriptional Complex to Inhibit Pediatric Sarcomas||University of Colorado Denver / Heide Ford, Ph.D.||Innovation Grants||2014||Colorado|
|Development of AAV Vectors for Efficient Targeting and Elimination of Osteosarcoma Tumor-Initiating Cells||University of Florida / Steven Ghivizzani, Ph.D.||Innovation Grants||2014||Florida|
|Correction of Hematopoietic Defects in Down Syndrome by Chromosome 21 Silencing||University of Massachusetts Medical School / Peter Newburger, M.D.||Innovation Grants||2014||Massachusetts|
|Targeted Therapy for Core Binding Factor Leukemia||University of Massachusetts Medical School / John Pulikkan, PhD||Young Investigator Grants||2014||Massachusetts|